Insulet(PODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PODD Insulet

Post-Market Trading 11-15 19:42:54 EST

260.12

-1.04

-0.40%

盘后260.12

+0.000.00%

16:31 EST

High264.71	Low257.43	Vol916.75K
Open261.00	D1 Closing261.16	Amplitude2.79%
Mkt Cap18.25B	Tradable Cap18.15B	Total Shares70.14M
T/O238.86M	T/O Rate1.31%	Tradable Shares69.77M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"PODD","market":"US","secType":"STK","nameCN":"Insulet","latestPrice":260.12,"timestamp":1731704400000,"preClose":261.16,"halted":0,"volume":916752,"hourTrading":{"tag":"盘后","latestPrice":260.12,"preClose":260.12,"latestTime":"16:31 EST","volume":13369,"amount":3477538.9324,"timestamp":1731706310294},"delay":0,"floatShares":69774557,"shares":70144775,"eps":5.735722,"marketStatus":"Post-Market Trading","change":-1.04,"latestTime":"11-15 19:42:54 EST","open":261,"high":264.71,"low":257.43,"amount":238861704.61679998,"amplitude":0.027876,"askPrice":261.14,"askSize":50,"bidPrice":259.48,"bidSize":50,"shortable":3,"etf":0,"ttmEps":5.735722,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1731718800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1179201600000,"exchange":"NASDAQ","adjPreClose":261.16,"preHourTrading":{"tag":"盘前","latestPrice":261.4,"preClose":261.16,"latestTime":"09:29 EST","volume":702,"amount":183321.7893,"timestamp":1731680999999},"postHourTrading":{"tag":"盘后","latestPrice":260.12,"preClose":260.12,"latestTime":"16:31 EST","volume":13369,"amount":3477538.9324,"timestamp":1731706310294},"volumeRatio":1.083029,"impliedVol":0.3516,"impliedVolPercentile":0.0079},"requestUrl":"/m/hq/s/PODD","defaultTab":"news","newsList":[{"id":"2483326636","title":"Insulet to Present at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2483326636","media":"Business Wire","labels":["Important Conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483326636?lang=en_us&edition=fundamental","pubTime":"2024-11-15 19:00","pubTimestamp":1731668400,"startTime":"0","endTime":"0","summary":"ACTON, Mass., November 15, 2024----Insulet Corporation  , the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced that management will present at three upcoming investor conferences :. The 6th Annual Wolfe Research Healthcare Conference in New York City on Wednesday, November 20, 2024 at 12:00 p.m.The Nasdaq 51st Investor Conference in London on Tuesday, December 10, 2024 at 5:30 a.m.The J.P. Morgan 43rd Annual Healthcare Conference in San Francisco on Tuesday, January 14, 2025 at 6:45 p.m.2024 Insulet Corporation. Omnipod is a registered trademark of Insulet Corporation. All rights reserved. All other trademarks are the property of their respective owners.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/25m4ZFAJAdyYkSFLorgUKA--~B/aD0yMzY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/102a11f1f40a75efeb528a2801c502c9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/25m4ZFAJAdyYkSFLorgUKA--~B/aD0yMzY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/102a11f1f40a75efeb528a2801c502c9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insulet-present-upcoming-investor-conferences-110000987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Important Conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","NQmain","PSQ","BK4566","BK4585","BK4588","MNQmain","SQQQ","BK4551","PODD","QID","WRD",".IXIC","QLD","TQQQ"],"gpt_icon":1},{"id":"2483863610","title":"KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2483863610","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483863610?lang=en_us&edition=fundamental","pubTime":"2024-11-14 05:05","pubTimestamp":1731531900,"startTime":"0","endTime":"0","summary":"MAHWAH, N.J., November 13, 2024----KORU Medical Systems, Inc.  , a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2024, and raised full year 2024 revenue, gross margin, and year-end cash guidance.Third quarter 2024 net revenues of $8.2 million, a 17% increase over the prior year period. Gross profit of $5.2 million, a 19% increase over the prior year period, and gross margin of 63%, a 140-basis point improvement over the prior year period. Ending cash balance of $8.8 million and year-to-date cash burn of $2.7 million, a 60% improvement over the prior year period. Raising full year 2024 net revenue guidance to $32.75 - $33.25 million, representing growth of 15% - 17% over the prior year; raising full year gross margin guidance to 62% - 63%, representing an improvement of 340 - 440 basis","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vb1._b7pVbNO2rfBF.vfgg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/3b2849aff47b47c9ef736f31fdf9a37c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vb1._b7pVbNO2rfBF.vfgg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/3b2849aff47b47c9ef736f31fdf9a37c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/koru-medical-systems-inc-announces-210500119.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KRMD","BK4588","KORU","BK4585","PODD","BK4082","BK4566","BK4551"],"gpt_icon":1},{"id":"2483020243","title":"Zacks.com featured highlights include NVIDIA, Insulet and Howmet Aerospace","url":"https://stock-news.laohu8.com/highlight/detail?id=2483020243","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483020243?lang=en_us&edition=fundamental","pubTime":"2024-11-13 15:15","pubTimestamp":1731482100,"startTime":"0","endTime":"0","summary":"Chicago, IL – November 13, 2024 – Stocks in this week’s article are NVIDIA Corp. NVDA, Insulet Corp. PODD and Howmet Aerospace Inc. HWM.To that end, NVIDIA Corp., Insulet Corp. and Howmet Aerospace Inc. have been selected as the top picks with a high net income ratio.NVIDIA Corporation leads in visual computing technologies and invented the graphic processing unit or GPU. The 12-month net profit margin of NVDA is 55%.The company’s expected earnings growth rate for the current year is 116.9%. NVIDIA Corporation currently has a Zacks Rank #2 (read more: NVIDIA Tops $3.5T Milestone - Good Time to Buy NVDA Stock?The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your f","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/SxIZoe6gTe1OM5yQjVVaKw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6d9e676bfa949d34d87584464569b788","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/SxIZoe6gTe1OM5yQjVVaKw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6d9e676bfa949d34d87584464569b788"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-com-featured-highlights-nvidia-071500814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["L","IE00B7KXQ091.USD","BK4579","HK0000306701.USD","BK4534","IE00B4JS1V06.HKD","BK4567","IE00BFSS7M15.SGD","IE0004091025.USD","LU0056508442.USD","SPY","SPXU","IE00BZ199S13.USD","IE00BK4W5L77.USD","OEF","BK4587","LU0053666078.USD","BK4581","LU0057025933.USD","LU0006306889.USD","HK0000320223.HKD","IE00BHPRN162.USD","PODD","BK4543","GB00BDT5M118.USD","NVDA","BK4551","BK4554","IE00BMPRXR70.SGD","2NVD.UK","SH","SDS","VOO","BK4082","BK4141","IE00B3M56506.USD","UPRO","IE00B775H168.HKD","BK4187","BK4549","HWM","3NVD.UK","OEX","IE0005OL40V9.USD","IE00BWXC8680.SGD","SSO",".SPX","ESmain","IE00B1BXHZ80.USD","IVV"],"gpt_icon":1},{"id":"2483065315","title":"Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More","url":"https://stock-news.laohu8.com/highlight/detail?id=2483065315","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483065315?lang=en_us&edition=fundamental","pubTime":"2024-11-13 04:05","pubTimestamp":1731441900,"startTime":"0","endTime":"0","summary":"On Monday, the S&P 500 eclipsed the coveted 6,000 mark, banking on the post-election rally. Donald Trump’s election victory has raised hopes of lower corporate taxes and deregulation, which helped the market benchmark to scale upward. The recent interest rate cuts by the Federal Reserve also boosted investors’ sentiment.Thus, investors should make the most of the S&P 500’s upward trajectory by favoring profitable stocks over unprofitable ones. Investors should consider metrics like accounting ratios for performance assessment. We have selected the most successful and commonly used profitability ratio to evaluate a company’s performance.To that end, NVIDIA Corporation NVDA, Insulet Corporation PODD and Howmet Aerospace Inc. HWM have been selected as the top picks with a high net income ratio.NVIDIA Corporation leads in visual computing technologies and invented the graphic processing unit or GPU. The 12-month net profit margin of NVDA is 55%.The company’s expected earnings growth rate f","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/esGBzeXBQnzFt0oz8IPN6w--~B/aD0zNDk7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f8e8dd74fec7b16eb85235be391efa80","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/esGBzeXBQnzFt0oz8IPN6w--~B/aD0zNDk7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f8e8dd74fec7b16eb85235be391efa80"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/buy-profitable-p-500-stocks-200500484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PODD","SPY","IE00BWXC8680.SGD","BK4551","IE0005OL40V9.USD","3NVD.UK","IE00B5949003.HKD","IE0004445239.USD","BK4082","IE00BMPRXR70.SGD","IE00B19Z8X17.USD","BK4187","BK4585","L","BK4549","BK4566","BK4554","IE00BKDWB100.SGD","BK4141","IE00BJTD4V19.USD","VOO","IE00BJJMRY28.SGD","HK0000320223.HKD","IE00BFSS8Q28.SGD","IE00BJTD4N35.SGD","IE00BK4W5L77.USD","IE00BMPRXN33.USD","LU0056508442.USD","IE00BDCRKT87.USD","HWM","BK4592","2NVD.UK","IE00B1BXHZ80.USD","LU0048584097.USD","IE00BFSS7M15.SGD","IE00BZ199S13.USD",".SPX","IE00B7KXQ091.USD","NVDA","IE00BK4W5M84.HKD","BK4503","BK4532","IE00BD6J9T35.USD","LU0006306889.USD","BK4587","BK4588","LU0057025933.USD","BK4550","HK0000306685.HKD","LU0053666078.USD"],"gpt_icon":1},{"id":"2483308043","title":"Why Insulet (PODD) is a Top Growth Stock for the Long-Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2483308043","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483308043?lang=en_us&edition=fundamental","pubTime":"2024-11-12 22:45","pubTimestamp":1731422712,"startTime":"0","endTime":"0","summary":"For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.Why This 1 Growth Stock Should Be On Your Watchlist. Growth investors build their portfolios around companies that are financially strong and have a bright future, and the Growth Style Score helps take projected and historical earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager . It is worn on the body for approximately three d","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/F3nzpi36wi9juoO_v9PrEA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/F3nzpi36wi9juoO_v9PrEA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-insulet-podd-top-growth-144512981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4194","PDM","BK4223","BK4551","BK4566","PODD","BK4082","BK4585","BK4588"],"gpt_icon":0},{"id":"2482086688","title":"PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2482086688","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482086688?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:10","pubTimestamp":1731417000,"startTime":"0","endTime":"0","summary":"Insulet Corporation PODD reported third-quarter 2024 adjusted earnings per share  of 90 cents, up significantly 26.8% from the year-ago period’s figure. The bottom line surpassed the Zacks Consensus Estimate by 16.9%.GAAP EPS was $1.08, up 45.9% from the year-ago figure of 74 cents.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the earnings announcement, PODD’s share price surged 2.9% to $275.7 yesterday.Revenues totaled $543.9 million, which beat the Zacks Consensus Estimate by 4.9%. The top line jumped 25.7% year over year . CER growth exceeded the company’s guidance of 21%.For 2024, the company now expects revenue growth to be between 20% and 21% . The Zacks Consensus Estimate for total revenues is pegged at $2.01 billion, suggesting 18.6% growth from the 2023 reported number.For the fourth quarter, Insulet projects revenue growth of 12-15%. The Zacks Consensus Estimate for total revenues is pegged at $564.5 million, suggesting 10.7% growth from the","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gl_19R8DekmvzA3Zg3Yozg--~B/aD0zOTQ7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0ebf144352a95b22dfed01b36b0e82c5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gl_19R8DekmvzA3Zg3Yozg--~B/aD0zOTQ7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0ebf144352a95b22dfed01b36b0e82c5"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/podd-stock-gains-q3-earnings-131000063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DGX","PODD"],"gpt_icon":0},{"id":"2482703864","title":"Insulet price target raised to $317 from $234 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2482703864","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482703864?lang=en_us&edition=fundamental","pubTime":"2024-11-12 19:45","pubTimestamp":1731411921,"startTime":"0","endTime":"0","summary":"Morgan Stanley raised the firm’s price target on Insulet  to $317 from $234 and keeps an Overweight rating on the shares. Insulet “had a strong 3Q print,” says the analyst, who cites “high quality growth, strong cash flow characteristics, and catalysts on the horizon” for the firm’s higher target following the company’s quarterly report.Early notable gainers among liquid option names on November 8th. Insulet price target raised to $270 from $260 at BTIG. Insulet Reports Strong Revenue Growth and Optimistic Outlook","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/8UXduVDD554L.fL21Hrlzg--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/1e5c62569304a546b8f4bd9cc2d706a2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/8UXduVDD554L.fL21Hrlzg--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/1e5c62569304a546b8f4bd9cc2d706a2"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/insulet-price-target-raised-317-114521361.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insulet-price-target-raised-317-114521361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PODD"],"gpt_icon":0},{"id":"2482617783","title":"Insulet Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2482617783","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482617783?lang=en_us&edition=fundamental","pubTime":"2024-11-11 20:27","pubTimestamp":1731328020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PODD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 11, 2024 07:27 ET (12:27 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"gpt_icon":0},{"id":"2482207762","title":"Barclays Adjusts Price Target on Insulet to $234 From $220, Maintains Equalweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2482207762","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482207762?lang=en_us&edition=fundamental","pubTime":"2024-11-11 19:52","pubTimestamp":1731325920,"startTime":"0","endTime":"0","summary":"Insulet (PODD) has an average outperform rating and a price target range of $234 to $317, according to analysts polled by Capital IQ.(MT Newswires covers equity, commodity and economic research from m","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PODD"],"gpt_icon":0},{"id":"2482021092","title":"Insulet price target raised to $234 from $220 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2482021092","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482021092?lang=en_us&edition=fundamental","pubTime":"2024-11-11 19:30","pubTimestamp":1731324620,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Insulet (PODD) to $234 from $220 and keeps an Equal Weight rating on the shares post the Q3 report. The ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/insulet-price-target-raised-to-234-from-220-at-barclays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/insulet-price-target-raised-to-234-from-220-at-barclays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PODD"],"gpt_icon":0},{"id":"2482337222","title":"Insulet’s Strong Performance and Growth Prospects Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2482337222","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482337222?lang=en_us&edition=fundamental","pubTime":"2024-11-11 14:25","pubTimestamp":1731306359,"startTime":"0","endTime":"0","summary":"Insulet (PODD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 7. Analyst Mike Kratky from Lee...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/insulets-strong-performance-and-growth-prospects-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/insulets-strong-performance-and-growth-prospects-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PODD"],"gpt_icon":0},{"id":"2482221499","title":"Insulet’s Strong Market Position and Growth Potential Justifies Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2482221499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482221499?lang=en_us&edition=fundamental","pubTime":"2024-11-11 14:15","pubTimestamp":1731305732,"startTime":"0","endTime":"0","summary":"Analyst Jeff Johnson from Robert W. Baird maintained a Buy rating on Insulet (PODD – Research Report) and keeping the price target at $280.00. Jeff...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/insulets-strong-market-position-and-growth-potential-justifies-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/insulets-strong-market-position-and-growth-potential-justifies-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PODD"],"gpt_icon":0},{"id":"2482426545","title":"Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2482426545","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482426545?lang=en_us&edition=fundamental","pubTime":"2024-11-10 20:59","pubTimestamp":1731243553,"startTime":"0","endTime":"0","summary":"Insulet Corporation  just released its quarterly report and things are looking bullish. It was overall a positive result, with revenues beating expectations by 4.7% to hit US$544m. Insulet also reported a statutory profit of US$1.08, which was an impressive 37% above what the analysts had forecast. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.NasdaqGS:PODD Earnings and Revenue Growth November 10th 2024. The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, they also r","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/oY9vQNBdaHAXW3k6VZJztA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/oY9vQNBdaHAXW3k6VZJztA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/results-insulet-corporation-beat-earnings-125913904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PODD"],"gpt_icon":0},{"id":"2482850652","title":"Analysts Are Bullish on These Healthcare Stocks: Insulet (PODD), Genfit (GNFTF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482850652","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482850652?lang=en_us&edition=fundamental","pubTime":"2024-11-10 09:42","pubTimestamp":1731202948,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insulet (PODD – Research Report) and Genfit (GNFTF –...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-insulet-podd-genfit-gnftf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-insulet-podd-genfit-gnftf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4585","BK4551","BK4082","GNFTF","BK4139","HCSG","BK4137","PODD","BK4588"],"gpt_icon":0},{"id":"2482342859","title":"Insulet Third Quarter 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2482342859","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482342859?lang=en_us&edition=fundamental","pubTime":"2024-11-09 20:50","pubTimestamp":1731156656,"startTime":"0","endTime":"0","summary":"Profit margin: 14% . The increase in margin was driven by higher revenue.NasdaqGS:PODD Earnings and Revenue Growth November 9th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 4.7%. Earnings per share  also surpassed analyst estimates by 37%.Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Medical Equipment industry in the US.The company's shares are up 14% from a week ago.You should always think about risks. Case in point, we've spotted   2 warning signs for Insulet  you should be aware of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insulet-third-quarter-2024-earnings-125056453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PODD"],"gpt_icon":0},{"id":"2482457320","title":"S&P 500 Gains and Losses Today: Axon Shares Surge as Taser Maker Tops Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2482457320","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482457320?lang=en_us&edition=fundamental","pubTime":"2024-11-09 05:39","pubTimestamp":1731101940,"startTime":"0","endTime":"0","summary":"The S&P 500 added 0.4% on Friday, Nov. 8, posting its highest-ever close to end a momentous week that included an election and a Fed rate cut.Axon Enterprise shares surged after the Taser maker beat quarterly estimates, boosted by sales growth for its cloud products, software, and services.Shares of Akamai Technologies dropped as the cloud services provider issued lower-than-expected guidance and announced plans to reduce its workforce.Shares of police and military equipment supplier Axon Enterprise  led the S&P 500 higher on Friday, surging 26.7% to an all-time high following a strong quarterly earnings report.The Taser manufacturer topped third-quarter sales and profit estimates, boosted by revenue growth from its marquee \"less-lethal\" weapon, its software and sensors business, and its cloud services products.The weakest performance in the S&P 500 on Friday belonged to shares of Akamai Technologies , which plunged 14.4% after the cloud services provider released its latest financial ","market":"sg","thumbnail":"https://www.investopedia.com/thmb/uXgJJepq0DQU83e46RgQiIhVKa0=/8256x5504/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-1818707875-c98f001f03bb49c7b8957da49a9d8a79.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/uXgJJepq0DQU83e46RgQiIhVKa0=/8256x5504/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-1818707875-c98f001f03bb49c7b8957da49a9d8a79.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investopedia.com/s-and-p-500-gains-and-losses-today-8742381","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["BK4560","IE00BMPRXQ63.HKD","LU1169589451.USD","BK4504","BK4020","IE00BN0W2V16.EUR","LU0079474960.USD","BK4116","IE00BMPRXN33.USD","SPY","BK4097","LU1917777945.USD","BK4548","SPXU","BK4550","OEF","IVV","BK4532","IE0008368304.USD","IE00B19Z9P08.USD","PODD","TASR","LU0348723411.USD","SG9999000418.SGD","BK4588","LU2023250504.SGD","BK4551","ANET","LU2023250843.SGD","FTNT","IE00B894F039.SGD","SH","BK4561","IE00B19Z9Z06.USD","SDS","VOO","BK4082","BK4535","LU2106854487.HKD","UPRO","ABNB","BK4187","BK4566","OEX","SSO",".SPX","ESmain","AXON","AKAM"],"gpt_icon":1},{"id":"2482432409","title":"Top Stock Movers Now: Axon Enterprise, Sweetgreen, Akamai Technologies, and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2482432409","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482432409?lang=en_us&edition=fundamental","pubTime":"2024-11-09 02:40","pubTimestamp":1731091242,"startTime":"0","endTime":"0","summary":"The Dow and S&P 500 climbed to fresh highs Friday, extending their post-election rally.Axon Enterprise shares surged, leading gains on the S&P 500 after the TASER maker posted better-than-expected results. Akamai Technologies warned it faced macroeconomic and geopolitical headwinds, and shares slumped.The Dow and S&P 500 climbed to fresh highs intraday Friday, extending their post-election rally. The Nasdaq was little changed and slightly lower.Axon Enterprise  was the best-performing stock in the S&P 500, with shares hitting an all-time high after the TASER maker posted better-than-expected results and guidance.Shares of DraftKings  gained after the online betting platform offered a strong outlook for fiscal 2025, even though its results were being hurt by payouts for bets on National Football League games.Insulet  shares took off after the insulin delivery device manufacturer reported a record jump in revenue and boosted its outlook as demand for its Omnipod grew.Akamai Technologies ","market":"hk","thumbnail":"https://www.investopedia.com/thmb/fXOBEpFDOHMB_S8_3z8wjN6B1m0=/5000x3335/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2151461215-3b102c20851b422fb4c17d929684834a.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/fXOBEpFDOHMB_S8_3z8wjN6B1m0=/5000x3335/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2151461215-3b102c20851b422fb4c17d929684834a.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investopedia.com/top-stock-movers-now-axon-enterprise-sweetgreen-akamai-technologies-and-more-8742223","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["OEF","BK4079","BK4566","BK4550","PODD","BK4548","OEX","BK4565","SG9999000418.SGD","SSO","DKNG","BK4209","AXON","LU1169590202.USD","BK4585","AKAM","BK4581","SPXU","BK4082","BK4187","BK4534",".SPX","BK4504","ESmain","VOO","BK4554","RDFN","SPY","LU1169589451.USD","LU2286300806.USD","SDS","BK4588","BK4150","IVV","BK4551","SG","LU1861559042.SGD","SH","UPRO","LU1861558580.USD","BK4116","BK4559"],"gpt_icon":0},{"id":"2482843952","title":"S&P 500 Breaks 6,000 Points, Dow Soars Above 44,000, Small Caps Eye Strongest Week In 4 Years, Tesla Hits $1 Trillion: What's Driving Markets Friday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2482843952","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482843952?lang=en_us&edition=fundamental","pubTime":"2024-11-09 02:35","pubTimestamp":1731090920,"startTime":"0","endTime":"0","summary":"The S&P 500 index surged past the 6,000-point milestone, setting fresh record highs, and small-cap stocks are poised for their best weekly performance since April 2024 as investor optimism surrounding the “Trump trade” continued to fuel a strong risk-on sentiment by the end of a wild week in the market.All major U.S. indices posted modest gains in midday trading, with the Dow Jones Industrial Average leading slightly, soaring beyond the 44,000-point mark. The blue-chip index is set for its best weekly performance in over a year.Friday's rise in the S&P 500 was powered by the utilities and real estate sectors, which had lagged post-election. Tech stocks took a breather following Thursday's rally.Tesla Inc.  surged 7%, pushing its weekly gains beyond 27% and propelling its market cap past $1 trillion.This move now places every \"Magnificent Seven\" tech stock in the trillion-dollar club, with the group's combined market cap topping $17 trillion.Treasury yields held steady, while the dollar","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/uoR4bMN1CoUqDdHAz2_j_g--~B/aD01NzQ7dz0xMDIwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/3afe728fdd15a5b3421b8c819b2e5136","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/uoR4bMN1CoUqDdHAz2_j_g--~B/aD01NzQ7dz0xMDIwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/3afe728fdd15a5b3421b8c819b2e5136"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/p-500-breaks-6-000-183520285.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1551013342.USD","TSLL","CPAY","UPRO","LU1551013425.SGD","TTD",".IXIC","MNST","FTNT","PSQ","PODD","VOO","QLD","BK4142","MNQmain","NET","SQQQ","NWS","QID","SH","ESmain","NQmain","SPXU","SDS","EOG","TSLA","UI","LU0266512127.USD","QQQ",".SPX","OEF","NRG","IVV","BK4077","OEX","TQQQ","BK4528","MSI","SPY","AXON","IE00B775SV38.USD","TOST","DKNG","LU1992135399.USD","LU2506952097.USD","SSO","PCOM"],"gpt_icon":1},{"id":"2482433135","title":"Costco Stock Breaks Out Past Buy Point, Reaches All-Time High","url":"https://stock-news.laohu8.com/highlight/detail?id=2482433135","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482433135?lang=en_us&edition=fundamental","pubTime":"2024-11-09 01:55","pubTimestamp":1731088504,"startTime":"0","endTime":"0","summary":"Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report.","market":"nz","thumbnail":"https://www.investors.com/wp-content/uploads/2018/10/Stock-Costco-05-shutt-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2018/10/Stock-Costco-05-shutt-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investors.com/stock-lists/new-highs/costco-stock-cost-insulet-podd/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU1035775433.USD","BK4566","LU2360106947.USD","LU2237438978.USD","LU2125154935.USD","LU0234572021.USD","BK4504","LU2210149790.SGD","LU0689472784.USD","BK4581","LU0256863811.USD","LU0234570918.USD","IE0008368304.USD","LU0820561818.USD","LU1069344957.HKD","LU1066053197.SGD","LU2095319765.USD","LU1551013425.SGD","BK4155","LU1571399168.USD","PODD","LU1496350171.SGD","LU0943347566.SGD","BK4551","COST","LU0385154629.USD","LU0471298694.HKD","LU1551013342.USD","BK4585","BK4588","LU0471298777.SGD","BK4596","LU0079474960.USD","LU1323610961.USD","LU1496350502.SGD","LU0820561909.HKD","LU2210150020.SGD","LU1066051498.USD","BK4550","LU2125154778.USD","IE00BZ1G4Q59.USD","BK4533","LU2360032135.SGD","BK4082","IE00BKVL7J92.USD","IE00B5TLWC47.USD","LU0417517546.SGD"],"gpt_icon":1},{"id":"2482438022","title":"Insulet Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2482438022","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482438022?lang=en_us&edition=fundamental","pubTime":"2024-11-09 01:53","pubTimestamp":1731088380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PODD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 08, 2024 12:53 ET (17:53 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.insulet.com","stockEarnings":[{"period":"1week","weight":0.066},{"period":"1month","weight":0.1351},{"period":"3month","weight":0.3496},{"period":"6month","weight":0.3946},{"period":"1year","weight":0.5053},{"period":"ytd","weight":0.2036}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":-0.004443},{"month":2,"riseRate":0.470588,"avgChangeRate":-0.007181},{"month":3,"riseRate":0.705882,"avgChangeRate":0.01102},{"month":4,"riseRate":0.470588,"avgChangeRate":0.022014},{"month":5,"riseRate":0.411765,"avgChangeRate":0.011414},{"month":6,"riseRate":0.833333,"avgChangeRate":0.053082},{"month":7,"riseRate":0.388889,"avgChangeRate":-0.010839},{"month":8,"riseRate":0.777778,"avgChangeRate":0.06814},{"month":9,"riseRate":0.555556,"avgChangeRate":0.016235},{"month":10,"riseRate":0.5,"avgChangeRate":-0.011455},{"month":11,"riseRate":0.666667,"avgChangeRate":0.083895},{"month":12,"riseRate":0.470588,"avgChangeRate":0.043302}],"exchange":"NASDAQ","name":"Insulet","nameEN":"Insulet"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Insulet(PODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Insulet(PODD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Insulet,PODD,Insulet股票,Insulet股票老虎,Insulet股票老虎国际,Insulet行情,Insulet股票行情,Insulet股价,Insulet股市,Insulet股票价格,Insulet股票交易,Insulet股票购买,Insulet股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Insulet(PODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Insulet(PODD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction